Parallel Synthesis of Drug-like 5-Amino-Substituted 1,2,4-Thiadiazole Libraries Using Cyclization Reactions of a Carboxamidine Dithiocarbamate Linker

Abstract

A general method has been developed for the solution-phase parallel synthesis of various drug-like 5-amino-substituted 1,2,4-thiadiazole derivatives, which employs initial cyclization reaction of carboxamidine dithiocarbamate 2 with p-toluenesulfonyl chloride. The carboxamidine dithiocarbamate 2 was produced by a three-component nucleophilic substitution reaction between carbon disulfide, benzamidine 1, and benzyl chloride. The key intermediate in this sequence, 5-(benzylsulfanyl)-3-phenyl-1,2,4-thiadiazole (3), is then transformed to the desired 5-amino-substituted 3-phenyl-1,2,4-thiadiazoles 6 in good yields and purities via oxidation of the sulfide group to form the corresponding sulfone followed by substitution reactions with various amines.

Key words

parallel synthesis - drug-like properties - 5-amino-1,2,4-thiadiazole - dithiocarbamate linker

References and Notes

• 1a Krchňák V. Holladay MW. Chem. Rev.  2002,  102:  61 
• 1b Thompson LA. Ellman JA. Chem. Rev.  1996,  96:  555 
• 1c Terrett NK. Gardner M. Gordon DW. Kobylecki RJ. Steele J. Tetrahedron  1995,  51:  8135 
• 2a Pal M. Batchu VR. Parasuraman K. Yeleswarapu KR. J. Org. Chem.  2003,  68:  6806 
• 2b Watanabe N. Kabasawa Y. Takase Y. Matsukura M. Miyazaki K. Ishihara H. Kodama K. Adachi H. J. Med. Chem.  1998,  41:  3367 
• 2c Napoletano M. Norcini G. Pellacini F. Marchini F. Morazzoni G. Fattori F. Ferlenga P. Pradella L. Bioorg. Med. Chem. Lett.  2002,  12:  5 
• 2d Van der Mey M. Hatzelmann A. Van der Laan IJ. Sterk GJ. Thibaut U. Timmerman H. J. Med. Chem.  2001,  44:  2511 
• 3a Mullican MD. Wilson MW. Connor DT. Kostlan CR. Schrier DJ. Dyer RD. J. Med. Chem.  1993,  36:  1090 
• 3b Song Y. Connor DT. Sercel AD. Sorenson RJ. Doubleday R. Unangst PC. Roth BD. Beylin VG. Beylin VG. Gilbertsen RB. Chan K. Schrier DJ. Guglietta A. Bornemeier DA. Dyer RD. J. Med. Chem.  1999,  42:  1161 
• 3c Labanauskas L. Kalcas V. Udrenaite E. Gaidelis P. Brukstus A. Dauksas A. Pharmazie  2001,  56:  617 
• 3d Boschelli DH. Connor DT. Bornemeier DA. Dyer RD. Kennedy JA. Kuipers PJ. Okonkwo GC. Schrier DJ. Wright CD. J. Med. Chem.  1993,  36:  1802 
• 4a El-Emam AA. Al-Deeb OA. Al-Omar M. Lehmann J. Bioorg. Med. Chem.  2004,  12:  5107 
• 4b Dogan HN. Duran A. Rollas S. Sener G. Uysal MK. Gülen D. Bioorg. Med. Chem.  2002,  10:  2893 
• 4c Hollar BS. Gonsalves R. Shenoy S. Eur. J. Med. Chem.  2000,  35:  267 
• 5a Chapleo CB. Myers M. Myers PL. Saville JF. Smith ACB. Stillings MR. Tulloch IF. Walter DS. Welbourn AP. J. Med. Chem.  1986,  29:  2273 
• 5b Chapleo CB. Myers PL. Smith AC. Stillings MR. Tulloch IF. Walter DS. J. Med. Chem.  1988,  31:  7 
• 5c Akbarzadeh T. Tabatabai SA. Khoshnoud MJ. Shafaghi D. Shafiee A. Bioorg. Med. Chem.  2003,  11:  769 
• 5d Foroumadi A. Tabatabai SA. Gitinezhad G. Zarrindast MR. Shafiee A. Pharm. Pharmacol. Commun.  2000,  6:  1 
• 6a Turner S. Myers M. Gadie B. Nelson AJ. Pape R. Saville JF. Doxey JC. Berridge TL. J. Med. Chem.  1988,  31:  902 
• 6b Turner S. Myers M. Gadie B. Hale SA. Horsley A. Nelson AJ. Pape R. Saville JF. Doxey JC. Berridge TL. J. Med. Chem.  1988,  31:  907 
• 6c Tyagi M. Kumar A. Oriental J. Chem.  2002,  18:  125 
• 7a Yoo S.-e. Seo J.-s. Yi KY. Gong Y.-D. Tetrahedron Lett.  1997,  38:  1203 
• 7b Yoo S.-e. Gong Y.-D. Seo J.-s. Sung M.-M. Lee S. Kim Y. J. Comb. Chem.  1999,  1:  177 
• 7c Gong Y.-D. Yoo S.-e. Bull. Korean Chem. Soc.  2001,  21:  941 
• 7d Gong Y.-D. Seo J.-s. Chon Y.-S. Hwang J.-Y. Park J.-Y. Yoo S.-e. J. Comb. Chem.  2003,  5:  577 
• 7e Lee IY. Kim SY. Lee JY. Yu C.-M. Lee DH. Gong Y.-D. Tetrahedron Lett.  2004,  45:  9319 
• 8a Fawzi AB. Macdonald D. Bendow LL. Smith Torhan A. Zhang HT. Weig BC. Ho G. Tulshian D. Linder ME. Graziano MP. Mol. Pharmacol.  2001,  59:  30 
• 8b Lanzafame A. Christopoulos A. J. Pharmacol. Exp. Ther.  2004,  308:  830 
• 8c Castro A. Castano T. Encinas A. Porcal W. Gil C. Bioorg. Med. Chem.  2006,  14:  1644 
• 9a Mamaeva EA. Bakibaev AA. Tetrahedron  2003,  59:  7521 
• 9b Kihara Y. Kabashima S. Uno K. Furukawa M. Synthesis  1990,  1020 
• 9c Smith RF. Feltz TP. J. Heterocycl. Chem.  1981,  18:  201 
• 10a Kurzer F. Adv. Heterocycl. Chem.  1965,  5:  119 
• 10b Taliani L. Perronnet J. J. Heterocycl. Chem.  1979,  16:  961 
• 11 Edward HK. Li D. Drug-like Properties: Concepts, Structure Design and Methods   Academic Press; London: 2007.  p.6-253  
• 12a Hwang JY. Choi H.-S. Lee D.-H. Yoo S.-e. Gong Y.-D. J. Comb. Chem.  2005,  7:  136 
• 12b Hwang JY. Choi H.-S. Lee D.-H. Yoo S.-e. Gong Y.-D. J. Comb. Chem.  2005,  7:  816 
• 12c Hwang JY. Gong Y.-D. J. Comb. Chem.  2006,  8:  297 
• 14a Oprea TI. J. Comput. Aided Mol. Des.  2000,  14:  251 
• 14b Veber DF. Johnson SR. Cheng H.-J. Smith BR. Ward KW. Kopple KD. J. Med. Chem.  2002,  45:  2615 

13

Accord for Excel, Version 6.1, Synopsys Scientific Systems, Ltd., 5 North Hill Road, Headingley, Leeds, UK.